Check up: COVID-19 is back in fashion
Health & Biotech
Here’s our fortnightly wrap of all the news driving ASX health stocks.
Of the ASX’s 132-odd small cap health stocks and of those which were trading on Wednesday, 64 were in positive territory over the last fortnight, 11 were flat and 67 saw their share prices fall.
Code | Name | Price $ (July 8) | 2 week return % | 1 year return % | Market cap |
---|---|---|---|---|---|
IMC | IMMURON LTD | 0.855 | 229 | 558 | $152,433,920 |
MEB | MEDIBIO LTD | 0.013 | 117 | -33 | $17,519,614 |
MEM | MEMPHASYS LTD | 0.105 | 106 | 75 | $79,167,256 |
RCE | RECCE PHARMACEUTICALS LTD | 1.35 | 99 | 500 | $194,627,888 |
NOX | NOXOPHARM LTD | 0.365 | 70 | -16 | $77,818,208 |
ADO | ANTEOTECH LTD | 0.035 | 67 | 138 | $57,543,180 |
FTT | FACTOR THERAPEUTICS LTD | 0.005 | 67 | 67 | $5,214,178 |
GTG | GENETIC TECHNOLOGIES LTD | 0.01 | 67 | 79 | $82,617,264 |
ATX | AMPLIA THERAPEUTICS LTD | 0.16 | 52 | 50 | $16,207,041 |
RSH | RESPIRI LTD | 0.15 | 50 | 50 | $97,925,968 |
JHL | JAYEX HEALTHCARE LTD | 0.036 | 44 | -35 | $6,349,069 |
IMM | IMMUTEP LTD | 0.21 | 35 | 0 | $102,402,496 |
LCT | LIVING CELL TECHNOLOGIES LTD | 0.016 | 33 | -27 | $9,143,056 |
PAL | PALLA PHARMA LTD | 1 | 30 | -7 | $125,947,976 |
BXN | BIOXYNE LTD | 0.014 | 27 | -39 | $8,962,036 |
CDX | CARDIEX LTD | 0.033 | 27 | 18 | $24,894,148 |
ANP | ANTISENSE THERAPEUTICS LTD | 0.105 | 24 | 150 | $51,343,756 |
RAC | RACE ONCOLOGY LTD | 0.975 | 23 | 1850 | $119,699,384 |
1ST | 1ST GROUP LTD | 0.04 | 21 | -55 | $16,984,676 |
IHL | INCANNEX HEALTHCARE LTD | 0.07 | 21 | 19 | $52,936,260 |
ANR | ANATARA LIFESCIENCES LTD | 0.16 | 19 | -47 | $7,976,989 |
GMV | G MEDICAL INNOVATION HOLDING | 0.059 | 18 | -70 | $39,163,408 |
EYE | NOVA EYE MEDICAL LTD | 0.39 | 17 | 43 | $56,004,444 |
IMU | IMUGENE LTD | 0.042 | 17 | 147 | $185,890,768 |
PAB | PATRYS LTD | 0.014 | 17 | -42 | $15,731,325 |
PXS | PHARMAXIS LTD | 0.089 | 16 | -61 | $35,177,180 |
IBX | IMAGION BIOSYSTEMS LTD | 0.048 | 14 | 3 | $36,565,448 |
MX1 | MICRO-X LTD | 0.16 | 14 | -49 | $57,146,856 |
RGS | REGENEUS LTD | 0.089 | 14 | 12 | $24,726,424 |
OIL | OPTISCAN IMAGING LTD | 0.049 | 14 | 0 | $23,411,162 |
PTX | PRESCIENT THERAPEUTICS LTD | 0.067 | 14 | 63 | $26,415,462 |
GLH | GLOBAL HEALTH LTD | 0.3 | 13 | 68 | $12,629,496 |
AT1 | ATOMO DIAGNOSTICS LTD | 0.39 | 13 | $218,820,352 | |
OSP | OSPREY MEDICAL INC-CDI | 0.046 | 12 | -42 | $68,944,288 |
SOM | SOMNOMED LTD | 1.39 | 12 | 4 | $115,035,448 |
PIQ | PROTEOMICS INTERNATIONAL LAB | 0.48 | 12 | 41 | $44,354,820 |
TD1 | TALI DIGITAL LTD | 0.029 | 12 | 142 | $21,729,852 |
BOT | BOTANIX PHARMACEUTICALS LTD | 0.049 | 11 | -80 | $47,662,204 |
CYP | CYNATA THERAPEUTICS LTD | 0.695 | 11 | -60 | $81,401,184 |
BWX | BWX LTD | 4.17 | 11 | 93 | $518,122,048 |
MMJ | MMJ GROUP HOLDINGS LTD | 0.1075 | 10 | -62 | $24,720,054 |
ICR | INTELICARE HOLDINGS LTD | 0.405 | 9 | $29,524,380 | |
MXC | MGC PHARMACEUTICALS LTD | 0.024 | 9 | -54 | $38,006,696 |
RHY | RHYTHM BIOSCIENCES LTD | 0.105 | 8 | -51 | $10,578,750 |
APH | AUSTRALIAN PRIMARY HEMP LTD | 0.135 | 8 | -39 | $9,416,943 |
ONT | 1300 SMILES LTD | 5.5 | 8 | -9 | $130,231,112 |
OSX | OSTEOPORE LTD | 0.625 | 8 | $63,269,064 | |
CTE | CRYOSITE LTD | 0.14 | 8 | 180 | $6,560,339 |
SCU | STEMCELL UNITED LTD | 0.015 | 7 | 0 | $9,624,125 |
ACR | ACRUX LTD | 0.155 | 7 | -16 | $26,143,146 |
CGS | COGSTATE LTD | 0.42 | 5 | 112 | $71,460,968 |
BNO | BIONOMICS LTD | 0.065 | 5 | 59 | $40,702,080 |
KZA | KAZIA THERAPEUTICS LTD | 0.55 | 5 | 41 | $52,029,104 |
AGH | ALTHEA GROUP HOLDINGS LTD | 0.36 | 4 | -70 | $83,991,600 |
S66 | STAR COMBO PHARMA LTD | 0.4 | 4 | -51 | $54,246,640 |
RNO | RHINOMED LTD | 0.08 | 4 | -75 | $20,304,730 |
ALC | ALCIDION GROUP LTD | 0.155 | 3 | -9 | $153,557,584 |
JHC | JAPARA HEALTHCARE LTD | 0.52 | 3 | -47 | $138,968,608 |
OCC | ORTHOCELL LTD | 0.35 | 3 | -20 | $64,675,436 |
GSS | GENETIC SIGNATURES LTD | 2.62 | 2 | 113 | $373,640,800 |
SDX | SIENNA CANCER DIAGNOSTICS LT | 0.07 | 1 | 17 | $27,659,298 |
SDI | SDI LTD | 0.7 | 1 | -19 | $83,205,872 |
VHT | VOLPARA HEALTH TECHNOLOGIES | 1.46 | 1 | -11 | $363,954,752 |
CYC | CYCLOPHARM LTD | 1.51 | 1 | 4 | $119,681,024 |
PBP | PROBIOTEC LTD | 1.995 | 0 | 25 | $149,183,840 |
PYC | PYC THERAPEUTICS LTD | 0.125 | 0 | 363 | $366,447,264 |
IPD | IMPEDIMED LTD | 0.071 | 0 | -51 | $73,479,976 |
CMP | COMPUMEDICS LTD | 0.42 | 0 | -39 | $74,408,440 |
VLS | VITA LIFE SCIENCES LTD | 0.57 | 0 | -15 | $30,827,088 |
NC6 | NANOLLOSE LTD | 0.041 | 0 | -31 | $4,335,750 |
NYR | NYRADA INC-CDI | 0.195 | 0 | $21,329,826 | |
SVA | SIMAVITA LTD-CDI | 0.019 | 0 | -10 | $10,711,785 |
CPH | CRESO PHARMA LTD | 0.031 | 0 | -93 | $11,233,823 |
ADR | ADHERIUM LTD | 0.025 | 0 | -4 | $15,047,658 |
FFC | FARMAFORCE LTD | 0.055 | 0 | -63 | $7,082,404 |
PSQ | PACIFIC SMILES GROUP LTD | 1.575 | -1 | 37 | $241,786,992 |
PAR | PARADIGM BIOPHARMACEUTICALS | 3.23 | -1 | 98 | $733,087,808 |
THC | THC GLOBAL GROUP LTD | 0.285 | -2 | -51 | $49,347,364 |
ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.043 | -2 | -85 | $7,448,094 |
PGC | PARAGON CARE LTD | 0.175 | -3 | -63 | $59,129,928 |
DXB | DIMERIX LTD | 0.35 | -3 | 218 | $69,212,256 |
1AD | ADALTA LTD | 0.097 | -3 | -46 | $15,902,724 |
RHT | RESONANCE HEALTH LTD | 0.155 | -3 | 19 | $68,784,960 |
AHX | APIAM ANIMAL HEALTH LTD | 0.45 | -3 | 0 | $52,468,712 |
M7T | MACH7 TECHNOLOGIES LTD | 0.88 | -3 | 19 | $206,251,504 |
AC8 | AUSCANN GROUP HOLDINGS LTD | 0.145 | -3 | -64 | $45,971,868 |
MDC | MEDLAB CLINICAL LTD | 0.145 | -3 | -67 | $40,552,972 |
DVL | DORSAVI LTD | 0.028 | -3 | -44 | $6,479,971 |
NEU | NEUREN PHARMACEUTICALS LTD | 1.23 | -4 | -13 | $147,543,584 |
HLA | HEALTHIA LTD | 0.975 | -4 | 8 | $61,458,788 |
PCK | PAINCHEK LTD | 0.11 | -4 | -42 | $113,907,464 |
MVF | MONASH IVF GROUP LTD | 0.53 | -5 | -58 | $206,506,464 |
CAJ | CAPITOL HEALTH LTD | 0.21 | -5 | -1 | $214,745,408 |
OPT | OPTHEA LTD | 2.32 | -5 | 194 | $624,446,016 |
EXL | ELIXINOL GLOBAL LTD | 0.17 | -6 | -95 | $32,782,300 |
VBS | VECTUS BIOSYSTEMS LTD | 0.68 | -6 | 100 | $16,085,275 |
UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.23 | -6 | -8 | $40,816,612 |
BD1 | BARD1 LIFE SCIENCES LTD | 0.028 | -7 | -7 | $38,281,180 |
OVN | OVENTUS MEDICAL LTD | 0.265 | -7 | -48 | $41,932,992 |
ATH | ALTERITY THERAPEUTICS LTD | 0.037 | -8 | 37 | $40,145,148 |
AZV | AZURE HEALTHCARE LTD | 0.073 | -8 | -8 | $20,745,794 |
ZLD | ZELIRA THERAPEUTICS LTD | 0.053 | -9 | -20 | $51,544,004 |
NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.21 | -9 | -25 | $16,460,763 |
BIT | BIOTRON LTD | 0.1 | -9 | 16 | $70,193,272 |
IDT | IDT AUSTRALIA LTD | 0.15 | -9 | -6 | $35,896,956 |
CDY | CELLMID LTD | 0.135 | -10 | -33 | $16,908,326 |
CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.135 | -10 | -25 | $12,571,875 |
PNV | POLYNOVO LTD | 2.36 | -10 | 43 | $1,560,167,808 |
MVP | MEDICAL DEVELOPMENTS INTERNA | 6.33 | -11 | 5 | $415,396,704 |
NXS | NEXT SCIENCE LTD | 1.31 | -11 | -66 | $237,826,144 |
OSL | ONCOSIL MEDICAL LTD | 0.115 | -12 | 117 | $95,289,104 |
ACW | ACTINOGEN MEDICAL LTD | 0.022 | -12 | 120 | $24,557,090 |
AVE | AVECHO BIOTECHNOLOGY LTD | 0.007 | -13 | 75 | $11,182,202 |
MDR | MEDADVISOR LTD | 0.48 | -13 | 49 | $118,424,656 |
ICS | ICSGLOBAL LTD | 1.7 | -13 | 79 | $18,026,832 |
RAP | RESAPP HEALTH LTD | 0.135 | -13 | -13 | $101,941,128 |
TLX | TELIX PHARMACEUTICALS LTD | 1.33 | -13 | -20 | $337,746,112 |
PAA | PHARMAUST LTD | 0.19 | -14 | 280 | $59,108,252 |
LSH | LIFESPOT HEALTH LTD | 0.04 | -15 | -43 | $3,871,532 |
SUD | SUDA PHARMACEUTICALS LTD | 0.028 | -18 | -56 | $4,409,887 |
VTI | VISIONEERING TECH-CDI | 0.017 | -19 | -74 | $15,418,144 |
IVX | INVION LTD | 0.008 | -20 | -47 | $44,004,852 |
ALT | ANALYTICA LTD | 0.002 | -20 | -60 | $7,039,225 |
NTI | NEUROTECH INTERNATIONAL LTD | 0.008 | -20 | -68 | $1,721,725 |
ZNO | ZOONO GROUP LTD | 2.32 | -23 | 2567 | $379,581,472 |
LBT | LBT INNOVATIONS LTD | 0.145 | -24 | 12 | $41,403,268 |
UCM | USCOM LTD | 0.195 | -25 | 44 | $29,216,526 |
ESE | ESENSE-LAB LTD-CDI | 0.018 | -25 | -25 | $9,180,684 |
BPH | BPH ENERGY LTD | 0.017 | -26 | 70 | $6,345,026 |
CAN | CANN GROUP LTD | 0.66 | -27 | -69 | $94,308,944 |
AMT | ALLEGRA ORTHOPAEDICS LTD | 0.215 | -33 | 65 | $22,444,396 |
HCT | HOLISTA COLLTECH LTD | 0.08 | -45 | 27 | $22,027,926 |
Immuron (ASX:IMC) is raising $US20m on the back of news that one of its drug candidates might help with COVID-19 symptoms.
While it’s better known for its travellers’ diarrhoea pills, a petri dish assessment of IMM-124E demonstrated neutralising activity against the virus, meaning it was able to inhibit replication.
Immuron’s theory is that diarrhoea is a common symptom in another coronavirus, bovine coronavirus, and it’s becoming an increasingly common COVID-19 symptom.
The US Centre for Disease Control and Prevention recently included it on its list of symptoms, while the inner-gut lining expresses high amounts of an enzyme which COVID-19 uses to gain entry into cells.
Medibio (ASX:MEB), which has a corporate well-being product ilumen, which screens people for symptoms of depression, anxiety, and stress, was up for no discernible reason.
As pointed out by Stockhead however, it submitted an application for FDA approval at the end of April for its sleep staging software MEBsleep, a system that uses artificial intelligence and “neural network methodology” to identify changes in the five stages of sleep necessary to diagnose sleep disorders.
It expects that process to take about four months, meaning a decision should come around the end of August, all things going well.
Sperm separator Memphasys (ASX:MEM) is moving into the commercialisation (read: money making) phase and rewarded its executives with vested performance options.
The milestone reached to allow the vesting was passing all legal and regulatory hurdles for distribution into Canada.
Commercial sales are expected to start once the company has completed verification and validation tests on the final manufactured product, around the December quarter this year — bang on when the company has guided that sales will start.
Recce Pharmaceuticals (ASX:RCE) went on a run after two of its compounds were selected to be part of COVID-19 tests run by the CSIRO and the Doherty Institute.
One of the compounds is among only few qualified treatments for sepsis or blood poisoning that also has a great capability against a broad range of superbugs, and is one of the first new anti-infectives to be developed in the last 30 years.
Recce’s youthful boss James Graham, 30, famously put his $100,000 house deposit into the drug company early last year.
And controversial cancer hopeful Noxopharm (ASX:NOX) says pre-clinical data from two research groups confirms that idronoxil, the active ingredient in its main drug candidate Veyonda helps restore immune function within ‘COLD’ micro-tumours by converting them to ‘HOT’.
A COLD tumour is one that contains few infiltrating T cells and are not recognised and do not provoke a strong response by the immune system, making them difficult to treat with current immunotherapies.